Purchases and Sales Made in Q3 2022 in Eledon Pharmaceuticals, Inc. (ELDN)
This table provides information about the institutional ownership of Eledon Pharmaceuticals, Inc. (ELDN) during Q3 2022. The information is specifically focused on institutions that hold shares of Eledon Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 04, 2022
Q3 2022
|
Cm Management, LLC
|
BUY
|
- |
20K+ 8.89% |
$49K - $77.6K
|
245K
$1.02M
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
18KNew |
$44K - $69.6K
|
18K
$74.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
10.2K+ 13.21% |
$25K - $39.5K
|
87.3K
$363K
|
|
|
Nov 08, 2023
Q3 2022
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
8.68K+ 14.69% |
$21.3K - $33.7K
|
67.7K
$282K
|
|
|
Nov 14, 2022
Q3 2022
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
8.68K+ 14.69% |
$21.3K - $33.7K
|
67.7K
$282K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
1.07K+ 2.22% |
$2.63K - $4.17K
|
49.4K
$205K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
679+ 0.53% |
$1.66K - $2.63K
|
129K
$539K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
38New |
$93.1 - $147
|
38
$158
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
- |
16+ 84.21% |
$39.2 - $62.1
|
35
$146
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-10- 10.87% |
$24.5 - $38.8
|
82
$341
|
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-67- 16.5% |
$164 - $260
|
339
$1.41K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-300- 0.93% |
$735 - $1.16K
|
31.9K
$133K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-395- 38.16% |
$968 - $1.53K
|
640
$2.66K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-899- 44.24% |
$2.2K - $3.49K
|
1.13K
$4.71K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.4K- 4.5% |
$3.43K - $5.43K
|
29.7K
$124K
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-2.8K- 6.22% |
$6.86K - $10.9K
|
42.2K
$176K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-3.62K- 78.14% |
$8.88K - $14.1K
|
1.01K
$4.22K
|
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-12.6K- 36.33% |
$30.8K - $48.8K
|
22.1K
$91.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-53.4K- 12.46% |
$131K - $207K
|
375K
$1.56M
|
|
|
Nov 14, 2022
Q3 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-81.6K- 6.25% |
$200K - $317K
|
1.22M
$5.09M
|
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-141K- 38.81% |
$345K - $546K
|
222K
$923K
|